Meiji Seika outlines plans for new fiscal year

Japan's Meiji Seika Kaisha is to  launch two new products in the second half of this fiscal year and increase its sales team by 20%,  according to the Nikkei Weekly. The Japanese financial newspaper claims  Meiji will double sales-force hiring from the previous fiscal year,  which ended in March, to a total of 800. During the period, the firm  will release one antidepressant, whilst granting sales rights to its  mainstay antibiotics to a Russian firm. Lastly, the Nikkei says Meiji  will divert its focus from Asia to emerging markets such as eastern  Europe and the Middle East.